Literature DB >> 16927183

Additive-induced metastable single crystal of mefenamic acid.

Eun Hee Lee1, Stephen R Byrn, M Teresa Carvajal.   

Abstract

PURPOSE: To utilize additives to develop a strategy and a method to grow single crystals that allow structure determination of a metastable form of a drug.
MATERIALS AND METHODS: The metastable form of mefenamic acid (MFA) was grown in the presence of various amounts of the structurally similar additive flufenamic acid (FFA) in ethanol. Single crystal X-ray analysis was performed on the single crystals of MFA II that were formed. The solubility of MFA in the presence of FFA was measured to elucidate the mechanism of MFA II formation.
RESULTS: A supersaturated solution of MFA in ethanol produced the metastable form using FFA as an additive. Ethanol-water mixtures and toluene were also used to investigate the relationships between form produced and solvent since these two solvent systems do not produce MFA II.
CONCLUSIONS: Additives can be used to obtain the metastable form of pharmaceutical compounds, and the relationships between molecules and solvent as well as between host and guest molecules are critical to obtaining the desired form.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16927183     DOI: 10.1007/s11095-006-9045-y

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  11 in total

Review 1.  Crystalline solids.

Authors:  S R Vippagunta; H G Brittain; D J Grant
Journal:  Adv Drug Deliv Rev       Date:  2001-05-16       Impact factor: 15.470

2.  Solubility behavior of polymorphs I and II of mefenamic acid in solvent mixtures.

Authors:  S Romero; B Escalera; P Bustamante
Journal:  Int J Pharm       Date:  1999-02-15       Impact factor: 5.875

3.  Solid-state characterization of mefenamic acid.

Authors:  Ramesh Panchagnula; Prakash Sundaramurthy; Omathanu Pillai; Shrutidevi Agrawal; Yasvanth Ashok Raj
Journal:  J Pharm Sci       Date:  2004-04       Impact factor: 3.534

4.  The predictably elusive form II of aspirin.

Authors:  Peddy Vishweshwar; Jennifer A McMahon; Mark Oliveira; Matthew L Peterson; Michael J Zaworotko
Journal:  J Am Chem Soc       Date:  2005-12-07       Impact factor: 15.419

5.  Processing of X-ray diffraction data collected in oscillation mode.

Authors:  Z Otwinowski; W Minor
Journal:  Methods Enzymol       Date:  1997       Impact factor: 1.600

6.  Dissolution behavior of polymorphs of chloramphenicol palmitate and mefenamic acid.

Authors:  A J Aguiar; J E Zelmer
Journal:  J Pharm Sci       Date:  1969-08       Impact factor: 3.534

7.  A kinetic study on the isothermal transition of polymorphic forms of tolbutamide and mefenamic acid in the solid state at high temperatures.

Authors:  T Umeda; N Ohnishi; T Yokoyama; T Kuroda; Y Kita; K Kuroda; E Tatsumi; Y Matsuda
Journal:  Chem Pharm Bull (Tokyo)       Date:  1985-05       Impact factor: 1.645

8.  Drugs which inhibit prostaglandin biosynthesis.

Authors:  R J Flower
Journal:  Pharmacol Rev       Date:  1974-03       Impact factor: 25.468

9.  Some physicochemical properties of mefenamic acid.

Authors:  A Adam; L Schrimpl; P C Schmidt
Journal:  Drug Dev Ind Pharm       Date:  2000-05       Impact factor: 3.225

10.  Structural studies of analgesics and their interactions. XII. Structure and interactions of anti-inflammatory fenamates. A concerted crystallographic and theoretical conformational study.

Authors:  V Dhanaraj; M Vijayan
Journal:  Acta Crystallogr B       Date:  1988-08-01
View more
  7 in total

1.  Concomitant polymorphism in confined environment.

Authors:  In Sung Lee; Alfred Y Lee; Allan S Myerson
Journal:  Pharm Res       Date:  2007-09-25       Impact factor: 4.200

2.  Polymorph formation and nucleation mechanism of tolfenamic acid in solution: an investigation of pre-nucleation solute association.

Authors:  Alessandra Mattei; Tonglei Li
Journal:  Pharm Res       Date:  2011-08-31       Impact factor: 4.200

3.  Quantum Chemical Study on Mefenamic Acid Polymorphic Forms.

Authors:  Svitlana V Shishkina; Yevhenii A Vaksler; Irina S Konovalova; Victoriya V Dyakonenko; Victoriya V Varchenko
Journal:  ACS Omega       Date:  2022-05-16

4.  4-Aminoquinaldine monohydrate polymorphism: Prediction and impurity aided discovery of a difficult to access stable form.

Authors:  Doris E Braun; Herbert Oberacher; Kathrin Arnhard; Maria Orlova; Ulrich J Griesser
Journal:  CrystEngComm       Date:  2015-10-15       Impact factor: 3.545

5.  Accessing Mefenamic Acid Form II through High-Pressure Recrystallisation.

Authors:  Nasir Abbas; Iain D H Oswald; Colin R Pulham
Journal:  Pharmaceutics       Date:  2017-05-16       Impact factor: 6.321

6.  Quasi-Isostructural Co(II) and Ni(II) Complexes with Mefenamato Ligand: Synthesis, Characterization, and Biological Activity.

Authors:  Michał Gacki; Karolina Kafarska; Anna Pietrzak; Izabela Korona-Głowniak; Wojciech M Wolf
Journal:  Molecules       Date:  2020-07-07       Impact factor: 4.411

7.  Isomorphism: 'molecular similarity to crystal structure similarity' in multicomponent forms of analgesic drugs tolfenamic and mefenamic acid.

Authors:  Subham Ranjan; Ramesh Devarapalli; Sudeshna Kundu; Subhankar Saha; Shubham Deolka; Venu R Vangala; C Malla Reddy
Journal:  IUCrJ       Date:  2020-01-07       Impact factor: 4.769

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.